In this open and engaging discussion, we hear from DCT industry veterans about how far we’ve come in incorporating mobile visits into decentralized clinical trials. Craig Lipset will share his early days at Pfizer at the dawn of the DCT movement and his early support of the model, and the challenges and barriers he faced. Deb will then report on her role and responsibilities working with teams to effectively incorporate mobile visits into study protocols. Then, together with facilitator Ellen Weiss, the group will imagine the future of mobile research and how it evolves within the DCT ecosystem.
Attendees will:
- Learn the genesis and evolution of the DCT movement!
- Compare past successes and challenges with successes and challenges of today.
- Understand the value of DCTs in today’s research landscape.